JPWO2019234075A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019234075A5
JPWO2019234075A5 JP2020567854A JP2020567854A JPWO2019234075A5 JP WO2019234075 A5 JPWO2019234075 A5 JP WO2019234075A5 JP 2020567854 A JP2020567854 A JP 2020567854A JP 2020567854 A JP2020567854 A JP 2020567854A JP WO2019234075 A5 JPWO2019234075 A5 JP WO2019234075A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
oxabolinin
benzo
dihydro
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020567854A
Other languages
English (en)
Japanese (ja)
Other versions
JP7317866B2 (ja
JP2021530440A (ja
JP2021530440A5 (https=
Publication date
Priority claimed from GBGB1809378.1A external-priority patent/GB201809378D0/en
Application filed filed Critical
Publication of JP2021530440A publication Critical patent/JP2021530440A/ja
Publication of JPWO2019234075A5 publication Critical patent/JPWO2019234075A5/ja
Publication of JP2021530440A5 publication Critical patent/JP2021530440A5/ja
Application granted granted Critical
Publication of JP7317866B2 publication Critical patent/JP7317866B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567854A 2018-06-07 2019-06-05 オキサボリニン環を含む新規ベンズイミドアミド化合物 Active JP7317866B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1809378.1A GB201809378D0 (en) 2018-06-07 2018-06-07 Novel compounds
GB1809378.1 2018-06-07
PCT/EP2019/064599 WO2019234075A1 (en) 2018-06-07 2019-06-05 Novel benzimidamides compounds comprising an oxaborinin ring

Publications (4)

Publication Number Publication Date
JP2021530440A JP2021530440A (ja) 2021-11-11
JPWO2019234075A5 true JPWO2019234075A5 (https=) 2022-06-09
JP2021530440A5 JP2021530440A5 (https=) 2022-06-09
JP7317866B2 JP7317866B2 (ja) 2023-07-31

Family

ID=62975712

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567854A Active JP7317866B2 (ja) 2018-06-07 2019-06-05 オキサボリニン環を含む新規ベンズイミドアミド化合物

Country Status (9)

Country Link
US (2) US11352372B2 (https=)
EP (1) EP3802550B1 (https=)
JP (1) JP7317866B2 (https=)
KR (1) KR102661802B1 (https=)
CN (2) CN112236433B (https=)
BR (1) BR112020024740A2 (https=)
ES (1) ES2973710T3 (https=)
GB (1) GB201809378D0 (https=)
WO (1) WO2019234075A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200040103A1 (en) 2018-03-14 2020-02-06 Genentech, Inc. Anti-klk5 antibodies and methods of use
GB201809378D0 (en) * 2018-06-07 2018-07-25 Glaxosmithkline Ip Dev Ltd Novel compounds
PE20221906A1 (es) 2019-09-18 2022-12-23 Genentech Inc Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecificos anti-klk5/klk7 y metodos de uso

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ578297A (en) * 2005-02-16 2010-11-26 Anacor Pharmaceuticals Inc Boron-containing small molecules
ES2575131T3 (es) 2007-12-03 2016-06-24 Obe Therapy Biotechnology Inhibidores boropéptidos de enteropeptidasa y sus usos en tratamientos de obesidad, sobrepeso y/o enfermedades asociadas con un metabolismo anormal de la grasa
CN102014927A (zh) * 2008-03-06 2011-04-13 安纳考尔医药公司 作为抗炎药的含硼的小分子
DK3097085T3 (da) 2014-01-23 2020-10-26 Sixera Pharma Ab Benzoxazinonderivater til behandling af hudsygdomme
PT3097084T (pt) 2014-01-23 2020-12-09 Sixera Pharma Ab Novos inibidores de calicreína 7
GB201809378D0 (en) * 2018-06-07 2018-07-25 Glaxosmithkline Ip Dev Ltd Novel compounds

Similar Documents

Publication Publication Date Title
JP2015508749A5 (https=)
JP2021063088A5 (https=)
JP2017528507A5 (https=)
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
JP2016503786A5 (https=)
JP2014502641A5 (https=)
JP2015524443A5 (https=)
JP2004525179A5 (https=)
JP2004504301A5 (https=)
JP2002080453A5 (https=)
RU2017127135A (ru) Терапевтическое средство против рака желчных протоков
JP2016508500A5 (https=)
JP2020507589A5 (https=)
JP2016506963A5 (https=)
JP2005506308A5 (https=)
JP2020502111A5 (https=)
JP2010516702A5 (https=)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
JP2016514141A5 (https=)
JP2020512337A5 (https=)
JP2019131544A5 (https=)
JP2009511450A5 (https=)
JP2017222722A5 (https=)
JP2019505529A5 (https=)
JP2004504400A5 (https=)